Stoke Therapeutics Inc (STOK)
11.69
+0.14
(+1.21%)
USD |
NASDAQ |
May 02, 16:00
11.69
0.00 (0.00%)
After-Hours: 17:29
Stoke Therapeutics Total Assets (Quarterly): 228.34M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 228.34M |
| September 30, 2023 | 239.89M |
| June 30, 2023 | 256.92M |
| March 31, 2023 | 281.80M |
| December 31, 2022 | 256.07M |
| September 30, 2022 | 277.63M |
| June 30, 2022 | 301.43M |
| March 31, 2022 | 315.94M |
| December 31, 2021 | 238.86M |
| September 30, 2021 | 253.77M |
| June 30, 2021 | 264.45M |
| Date | Value |
|---|---|
| March 31, 2021 | 278.91M |
| December 31, 2020 | 297.92M |
| September 30, 2020 | 199.94M |
| June 30, 2020 | 210.21M |
| March 31, 2020 | 220.84M |
| December 31, 2019 | 228.75M |
| September 30, 2019 | 238.83M |
| June 30, 2019 | 246.37M |
| March 31, 2019 | 102.93M |
| December 31, 2018 | 107.54M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
199.94M
Minimum
Sep 2020
315.94M
Maximum
Mar 2022
254.57M
Average
253.77M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | 18.62M |
| iBio Inc | 34.02M |
| Actinium Pharmaceuticals Inc | 88.35M |
| Lixte Biotechnology Holdings Inc | 4.309M |
| Fate Therapeutics Inc | 506.22M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 68.78M |
| Shareholders Equity (Quarterly) | 159.56M |
| Current Ratio | 6.987 |